Your browser doesn't support javascript.
loading
Diabetes mellitus and hyperglycemia are associated with inferior oncologic outcomes in adrenocortical carcinoma.
Wrenn, Sean M; Pandian, T K; Gartland, Rajshri M; Fong, Zhi Ven; Nehs, Matthew A.
Afiliación
  • Wrenn SM; Department of Surgery, Division of Surgical Oncology, Rush University Medical Center, 1725 W. Harrison St. Suite 810, Chicago, IL, 60612, USA. Swrenn1@bwh.harvard.edu.
  • Pandian TK; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. Swrenn1@bwh.harvard.edu.
  • Gartland RM; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. Swrenn1@bwh.harvard.edu.
  • Fong ZV; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Nehs MA; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Langenbecks Arch Surg ; 406(5): 1599-1606, 2021 Aug.
Article en En | MEDLINE | ID: mdl-33521844

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Corteza Suprarrenal / Carcinoma Corticosuprarrenal / Diabetes Mellitus / Diabetes Mellitus Tipo 2 / Hiperglucemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Langenbecks Arch Surg Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Corteza Suprarrenal / Carcinoma Corticosuprarrenal / Diabetes Mellitus / Diabetes Mellitus Tipo 2 / Hiperglucemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Langenbecks Arch Surg Año: 2021 Tipo del documento: Article